Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2022
Reporting Period: This filing reports on events occurring on May 10, 2022, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure of upcoming communications rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers have scheduled upcoming presentations to investors and analysts.
Guidance, Outlook, and Management Commentary
- Investor Presentations: Executive officers intend to use the material provided in Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated May 2022) for upcoming meetings with investors and analysts.
- Regulation FD Disclosure: The information in this filing, including the referenced Exhibit 99.1, is furnished pursuant to Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated May 2022) for specific financial guidance, strategic outlook, and operational updates, as this 8-K only references the presentation.
- Confirm the dates and details of the upcoming investor and analyst presentations mentioned by management.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act unless specifically referenced in other filings.